Expert Interview
A Second View: Discussing the use and potential of Rezurock for treatment of Graft vs. Host disease (cGVHD)
Ticker(s): SNYInstitution: HCA Healthcare
Start Date: 12/15 - Present
Manages treatment for 20 patients with cGVHD and is familiar with Rezurock as a treatment option.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
